Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months

Colorectal cancer in the young: What do we know and what can we do?

Rectal cancers: Positioning of watchful waiting and minimally invasive procedures

Beyond second-line therapy: New hope for mCRC patients in Egypt

Multi-target kinase inhibitors: From data to practice

Using genetic testing to tailor chemotherapy

Differences in hormone therapy for patients with advanced metastatic prostate cancer

Role of interventional oncology for immunology treatment

Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour)

Emerging role of radioembolization for hepatocellular carcinoma

State of art in systemic management of nmCRPC

EAU prostate cancer guidelines 2019: What changed and why?